Drug intelligence / Profile preview

KM R-Fit

Development stage: Unknown
Lead developer: Kaken Pharmaceutical
Administration: Implant

Overview

KM R-Fit is a carbonate apatite-based bone substitute material developed for use in periodontal regenerative surgery. It is specifically designed to be used in combination with Regros (trafermin), a recombinant human basic fibroblast growth factor (rh-bFGF), to treat moderate to severe periodontitis characterized by vertical bone defects. Carbonate apatite is a bioresorbable ceramic that closely mimics the chemical composition of natural bone mineral, facilitating osteoconduction and gradual replacement by host bone through the natural remodeling process. In clinical applications, the material serves as a scaffold that supports the growth of new alveolar bone and periodontal tissues when applied to the site of the defect during flap surgery.

Brand names: KM R-Fit
Other names: carbonate apatiteCO3ApCO-3ApCO 3Ap

Beyond the preview

Go deeper on KM R-Fit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KM R-Fit.

Explore the full profile